Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database*

References

• Ponzoni M, Ferreri AJM, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25:3168–3173.
   PubMed Web of Science ®Google Scholar
• Ferreri AJM, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol. 2004;127:173–183.
   PubMed Web of Science ®Google Scholar
• Chapin JE, Davis LE, Kornfeld M, et al. Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand. 1995;91:494–499.
   PubMed Web of Science ®Google Scholar
• Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000;111:826–834.
   PubMed Web of Science ®Google Scholar
• Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007;109:478–485.
   PubMed Web of Science ®Google Scholar
• Ferreri AJM, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004;15:1215–1221.
   PubMed Web of Science ®Google Scholar
• Shimada K, Matsue K, Yamamoto K, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008;26:3189–3195.
   PubMed Web of Science ®Google Scholar
• Mallin K, Palis BE, Watroba N, et al. Completeness of American Cancer Registry Treatment Data: implications for quality of care research. J Am Coll Surg. 2013;216:428–437.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer–approved and –nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27:4177.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351.
   PubMed Web of Science ®Google Scholar
• Joinpoint Regression Program version 4.3.1.0– Statistical methodology and applications branch, Surveillance Research Program; Bethesda (MD): National Cancer Institute; 2016.
   Google Scholar
• Deyo Richarda, Cherkin Danielc, Ciol Marciaa. Adapting a clinical comorbidity index for use with ICD-g-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
   PubMed Web of Science ®Google Scholar
• Whoterspoon AC. Lymphoma. Plainview (NY): Cold Spring Harbor Laboratory Press; 1997.
   Google Scholar
• Harlan LC, Greene AL, Clegg LX, et al. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23:9079–9088.
   PubMed Web of Science ®Google Scholar
• Walker GV, Grant SR, Guadagnolo BA, et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol. 2014;32:3118.
   PubMed Web of Science ®Google Scholar
• Han X, Jemal A, Flowers CR, et al. Insurance status is related to diffuse large B-cell lymphoma survival. Cancer. 2014;120:1220–1227.
   PubMed Web of Science ®Google Scholar
• Tao L, Foran JM, Clarke CA, et al. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood. 2014;123:3553–3562.
   PubMed Web of Science ®Google Scholar
• Held G, Murawski N, Ziepert M, et al. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol. 2014;32:1112.
   PubMed Web of Science ®Google Scholar
• Jackson MW, Rusthoven CG, Jones BL, et al. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma. Am J Hematol. 2016;91:476.
   PubMed Web of Science ®Google Scholar
• Schlossberg D. Clinical infectious disease. UK: Cambridge University Press; 2008.
   Google Scholar
• Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas; a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354–371.
   PubMed Web of Science ®Google Scholar
• Pereira B, Gourgou-Bourgade S, Azria D, et al. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question? J Clin Oncol. 2008;26:5133–5134.
   PubMed Web of Science ®Google Scholar
• Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 2005;23:5027–5033.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP Chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242.
   PubMed Web of Science ®Google Scholar
• Artero G, Angrigiani C, Rancati A, et al. Abstract. Plast Reconstr Surg Global Open. 2016;4:21.
   Google Scholar
• Mink SA, Armitage JO. High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin’s disease and non-Hodgkin’s lymphoma. Oncologist. 2001;6:247–256.
   PubMed Web of Science ®Google Scholar
• Stiff PJ, Unger JM, Cook JR, et al. Autologous transplantation as consolidation for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 2013;369:1681–1690.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kimura M, Watanabe Y, et al. Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis. Bone Marrow Transplant. 2001;27:89–91.
   PubMed Web of Science ®Google Scholar
• Koizumi M, Nishimura M, Yokota A, et al. Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001;27:1101–1103.
   PubMed Web of Science ®Google Scholar
• Bickford CB. Correspondence. Baltimore (MD): Johns Hopkins University Press; 2012.
   Google Scholar
• Shimada K, Murase T, Matsue K, et al. Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients. Cancer Sci. 2010;101:1480–1486.
   PubMed Web of Science ®Google Scholar